Michael Jordan v. Jewel Food Stores: The Seventh Circuit Explores the Boundaries of Commercial Speech

21 February 2014 Wisconsin Appellate Law Blog

When and how the First Amendment applies is normally a complicated question. In a case decided earlier this week, Michael Jordan v. Jewel Food Stores, Inc., No. 12-1992, the parties teamed up to present an issue on commercial speech for the Seventh Circuit.

 

When Bulls legend Michael Jordan was inducted into the NBA Hall of Fame, Sports Illustrated created a special commemorative issue, giving Jewel a free ad in the issue in exchange for Jewel’s agreement to stock and sell it. Jewel’s ad featured a pair of #23 basketball sneakers, a short paragraph of congratulations to Jordan, and Jewel’s logo and slogan. Jordan brought a federal Lanham Act false-endorsement claim and state-law claims, including for false publicity, against Jewel for its use of his identity.

Jewel asserted immunity from suit under the First Amendment, arguing that the ad was fully protected noncommercial speech. Jordan maintained that the ad was commercial speech, entitled to lesser constitutional protection. Commercial speech is generally defined as “speech that proposes a commercial transaction.” 

The district court sided with Jewel, mainly because it did not seek to have readers enter into any specific commercial transaction. The Seventh Circuit reversed, framing its analysis with three guideposts: whether the speech is an advertisement, whether it refers to a specific product, and whether the speaker has an economic motivation for the speech. These are not all necessary components of a finding of commercial speech.

The Court of Appeals stressed that while propositions of specific commercial transactions are at the “core” of commercial speech, such propositions do not demarcate the outer limits of what is commercial speech. Rather, even if speech does something more than (or in addition to) proposing a commercial transaction, it can still be commercial. The court recognized that “[i]f the literal import of the words were all that mattered, this celebratory tribute would be noncommercial.” But Jewel’s ad served two functions: (1) congratulating Jordan, and (2) enhancing Jewel’s brand by associating itself with Jordan in the minds of basketball fans and Chicago consumers. Given that a “common-sense distinction” between commercial and noncommercial speech was proper, in this context, one had to account for the varied, often subtle forms of modern advertising. Thus, an ad’s failure to refer to a specific product is relevant, but not dispositive, according to the Seventh Circuit. The court had no trouble answering the question, “What does [the ad] invite the readers to buy?” The answer: “Whatever they need from a grocery store.” In essence, it found that this kind of brand advertising isn’t any less commercial than product advertising, since its “commercial nature is readily apparent” and it “aimed at promoting goodwill for the Jewel-Osco brand by exploiting public affection for Jordan.” That is, however sincere its congratulations, Jewel still “had something to gain” from the ad. 

Businesses might well wonder what kinds of corporate speech don’t fit within this last description. In an interesting passage, the court distinguished between the Jordan “superstar” context and the context of an ad promoting a local community group. The opinion draws an intriguing distinction:  the Jewel ad could only be seen as benefiting Jewel, since Jordan needed no additional promotion. A less well-known group, on the other hand, might well receive benefits from an ad, potentially permitting proper classification as noncommercial speech.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.

Related Services

Insights

MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
BRG Healthcare Leadership Conference
06 December 2019
Washington, D.C.
CTeL Telehealth Fall Summit 2019
04-06 December 2019
Washington, D.C.